Literature DB >> 20013266

Pentoxifylline for the treatment of anterior uveitis in Behcet's disease: possible alternative for TNF blockers.

Simone Appenzeller1, Elizabeth Hazel.   

Abstract

Behcet's disease is an inflammatory disorder of unknown cause, characterized by recurrent oral aphthous ulcers, genital ulcers, uveitis, and skin lesions. All these common manifestations are self-limiting except for the ocular attacks. The objective of the present study is to report the efficacy of pentoxifylline for ocular involvement in Behcet's disease. We report a patient with ocular involvement secondary to Behcet's disease which was corticosteroid dependent and refractory to azathioprine treatment. Pentoxifylline was added with amelioration of inflammation. Pentoxifylline may be a useful treatment option in patients with Behcet's disease, where other immunosuppressives have failed or are contra-indicated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20013266     DOI: 10.1007/s00296-009-1305-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  14 in total

Review 1.  Behçet's disease.

Authors:  T Sakane; M Takeno; N Suzuki; G Inaba
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

Review 2.  Practical treatment recommendations for pharmacotherapy of Behçet's syndrome.

Authors:  H Yazici; C G Barnes
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 3.  Uveitis in Behçet's disease.

Authors:  R B Nussenblatt
Journal:  Int Rev Immunol       Date:  1997       Impact factor: 5.311

Review 4.  Behçet's disease: ocular effects and treatment.

Authors:  Christoph M E Deuter; Ina Kötter; Graham R Wallace; Philip I Murray; Nicole Stübiger; Manfred Zierhut
Journal:  Prog Retin Eye Res       Date:  2007-11-26       Impact factor: 21.198

Review 5.  Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease.

Authors:  G Hatemi; A Silman; D Bang; B Bodaghi; A M Chamberlain; A Gul; M H Houman; I Kötter; I Olivieri; C Salvarani; P P Sfikakis; A Siva; M R Stanford; N Stübiger; S Yurdakul; H Yazici
Journal:  Ann Rheum Dis       Date:  2008-04-17       Impact factor: 19.103

Review 6.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

7.  Treatment and visual prognosis in Behçet's disease.

Authors:  D Benezra; E Cohen
Journal:  Br J Ophthalmol       Date:  1986-08       Impact factor: 4.638

8.  A double blind study of colchicine in Behçet's disease.

Authors:  E Aktulga; M Altaç; A Müftüoglu; Y Ozyazgan; H Pazarli; Y Tüzün; B Yalçin; H Yazici; S Yurdakul
Journal:  Haematologica       Date:  1980-06       Impact factor: 9.941

9.  Leucocyte movement and colchicine treatment in Behcet's disease.

Authors:  N Matsumura; Y Mizushima
Journal:  Lancet       Date:  1975-10-25       Impact factor: 79.321

Review 10.  Behçet's Disease.

Authors:  V G Kaklamani; G Vaiopoulos; P G Kaklamanis
Journal:  Semin Arthritis Rheum       Date:  1998-02       Impact factor: 5.532

View more
  2 in total

1.  Evaluation of factors for predicting risk of uveitis recurrence in Behcet's disease patients.

Authors:  Jianfei Cai; Lin Qi; Yong Chen; Jun Zou; Yan Shen; Dan Luo; Huafang Bao; Jingfen Ye; Haifen Ma; Jian-Long Guan
Journal:  Braz J Med Biol Res       Date:  2020-05-08       Impact factor: 2.590

2.  Evaluation of intravitreal injection of pentoxifylline in experimental endotoxin-induced uveitis in rabbits.

Authors:  Mohammad Reza Khalili; Amin Hossein Amini; Mohammad Abbaszadeh Hasiri; Effat Baghaei Moghaddam; Masoomeh Eghtedari; Mohammad Azizzadeh; Mousa Zare; Masood Yasemi
Journal:  Vet Res Forum       Date:  2018-09-15       Impact factor: 1.054

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.